Literature DB >> 12571213

11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.

Dominique Delbeke1, C Wright Pinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12571213

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  9 in total

1.  Quantitative liver lesion volume determination by nanoparticle-based SPECT.

Authors:  Dániel S Veres; Domokos Máthé; Ildikó Futó; Ildikó Horváth; Akos Balázs; Kinga Karlinger; Krisztián Szigeti
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 2.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.

Authors:  Y Yamamoto; Y Nishiyama; N Kimura; R Kameyama; N Kawai; T Hatakeyama; M Kaji; M Ohkawa
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

4.  Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis.

Authors:  Fang Zheng; Amanda Sparkes; Patrick De Baetselier; Steve Schoonooghe; Benoit Stijlemans; Serge Muyldermans; Véronique Flamand; Jo A Van Ginderachter; Nick Devoogdt; Geert Raes; Alain Beschin
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

5.  [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice.

Authors:  Lei Li; Li Che; Chunmei Wang; Joseph E Blecha; Xiaolei Li; Henry F VanBrocklin; Diego F Calvisi; Michelle Puchowicz; Xin Chen; Youngho Seo
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

6.  Kinetic analysis of dynamic (11)C-acetate PET/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions.

Authors:  Li Huo; Jinxia Guo; Yonghong Dang; Jinqiao Lv; Youjing Zheng; Fang Li; Qingguo Xie; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

7.  Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma.

Authors:  Patricia Larsson; Dag Arvidsson; Mikael Björnstedt; Bengt Isaksson; Ulf Jersenius; Hooman Motarjemi; Hans Jacobsson
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01

Review 8.  Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).

Authors:  Evelina Miele; Gian Paolo Spinelli; Federica Tomao; Angelo Zullo; Filippo De Marinis; Giulia Pasciuti; Luigi Rossi; Federica Zoratto; Silverio Tomao
Journal:  J Exp Clin Cancer Res       Date:  2008-10-17

Review 9.  Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor.

Authors:  Masakatsu Tsurusaki; Masahiko Okada; Hiroyuki Kuroda; Mitsuru Matsuki; Kazunari Ishii; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2013-03-26       Impact factor: 7.527
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.